Mia Ferraiolo Wednesday, December 18, 2024

Disease pathogenesis is often context-dependent, specifically on tissue expression profiles within a given disease context. However, tissue expression profile of...

Mia Ferraiolo Wednesday, December 18, 2024

In the drug discovery pipeline, evaluating multiple pathways between a drug target and disease is crucial for identifying potential therapeutic...

Mia Ferraiolo Wednesday, December 18, 2024

While there is great interest in the scientific community to investigate drug targets and biomarkers from public immune-oncology data sources...

Thursday, October 17, 2024

In an era of near-limitless public experimental data but little standardization, meaningful insights are lost to noise. Large collections of...

Thursday, October 17, 2024

In an era of near-limitless public experimental data but little standardization, meaningful insights are lost to noise. Large collections of...

Thursday, October 17, 2024

Cancer cell line models have been a cornerstone of cancer research for decades. Cancer cell lines profiling can be a...

Thursday, October 17, 2024

There's more than one way to probe our OncoLand data. With the OmicSoft Studio graphical user interface (GUI), you won't...

Thursday, October 17, 2024

Per feedback from recent trainings, we are hosting a training focused on biomarkers and drug target investigation through effectively utilizing...

Thursday, October 17, 2024

In this 90-minute training, attendees will learn how to use basic expression analysis (example RNA-seq) functionalities in QIAGEN OmicSoft Studio...

Thursday, October 17, 2024

Are you interested in exploring how you can evaluate phenotypic differences between custom cohorts? You can learn more about drug...

1 2 3
Sample to Insight
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.